Sha Xu
State Key Laboratory Of Oncology In South China, Guangdong Key Laboratory Of Nasopharyngeal Carcinoma Diagnosis And Therapy
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Development of a Classifier for Metabolic Subtypes of Nasopharyngeal Carcinoma to Guide Personalized Immunotherapy Strategies: Biomarker Analysis of the Phase III CONTINUUM and DIPPER Trials.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 06, 2026
Author Correction: Proteogenomic insights into the biology and treatment of pan-melanoma.
Journal: Cell discovery
Published: November 18, 2025
PD-1 inhibitors combined with induction chemotherapy followed by chemoradiotherapy in HPV-negative locally advanced head and neck squamous cell carcinoma: a real-world study.
Journal: Cancer immunology, immunotherapy : CII
Published: August 10, 2025
Multi-omic characterization of nasopharyngeal carcinoma delineates the subtype-specific landscape of response to induction chemotherapy.
Journal: Nature cancer
Published: June 02, 2025
IDH1 Reprograms Nucleotide Metabolism by Inducing Chromatin Remodeling and DHODH Transcription to Drive Chemoresistance in Nasopharyngeal Carcinoma.
Journal: Cancer research
Published: June 01, 2025
MedNext-Insight Model for Automated Metabolic Tumor Volume Delineation on Computed Tomography and Prognostic Value in Nasopharyngeal Carcinoma.
Journal: International journal of radiation oncology, biology, physics
Published: May 15, 2025
Structural analysis of ASCH domain-containing proteins and their implications for nucleotide processing.
Journal: Structure (London, England : 1993)
Published: March 07, 2025
Fast self-supervised discrete graph clustering with ensemble local cluster constraints.
Journal: Neural networks : the official journal of the International Neural Network Society
Published: February 04, 2025
An interplay between human genetics and intratumoral microbiota in the progression of colorectal cancer.
Journal: Cell host & microbe
Published: September 25, 2024
LncRNA DYNLRB2-AS1 promotes gemcitabine resistance of nasopharyngeal carcinoma by inhibiting the ubiquitination degradation of DHX9 protein.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: March 21, 2024
PJA1-mediated suppression of pyroptosis as a driver of docetaxel resistance in nasopharyngeal carcinoma.
Journal: Nature communications
Published: September 27, 2023
Last Updated: 09/26/2026